Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THVD-201 in Overactive Bladder
NCT02485067Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Jan 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolterodine + pilocarpine in overactive bladder (OAB), sponsored by SK Chemicals. Started Jan 2015; status: completed.
02
Drugs
tolterodine + pilocarpine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02485067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02485067.